PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Endocannabinoid Hydrolase Inhibitors
Jump to section
- Article
- Abstract
- I. Introduction to the Endocannabinoid System
- II. Identification and Molecular Characterization of Endocannabinoid Hydrolases in the Nervous System
- III. Development of Endocannabinoid Hydrolase Inhibitors
- IV. Comparison of the Neurobehavioral Effects of FAAH and MAGL Inhibition
- V. Non-CB-Mediated Effects
- VI. Conclusions, Clinical Implications, and Future Directions
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters